Executive Summary
Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office located in Tokyo. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the Company's website, www.Abcam.com. The antibodies are sold almost entirely under the Abcam brand name. The Company's vision is to build the largest online antibody resource in the world. Abcam maintains an online catalogue of over 17,000 products, most of which are antibodies, from over 170 suppliers supported by up-to-date and detailed technical data sheets, which are created by the Company. The Company employs 78 staff.
In the financial year ended 30 June 2005, the Company achieved sales of £12.1 million (2004:£6.7 million) and pre-tax profits of £ 3.0 million (2004: £1.4 million).
Company History
- The Company was founded by Dr Jonathan Milner (CEO), Dr David Cleevely (Chairman) and Professor Tony Kouzarides (non-executive director) in February 1998.
- The Company reported its first profit in the financial year ended 30 June 2003.
- In April 2005, the Company moved its headquarters to larger premises in Cambridge, UK and its US subsidiary to larger premises in Cambridge, Massachusetts.
Current Events
Business Model
Abcam produces and distributes its own and third party antibodies and related products to academic and commercial users throughout the world via an online catalogue featuring detailed technical data sheets on each product.[1]
Products/Services
Segments/Customers
Universities, institutes and hospitals as well as pharmaceutical and biotechnology companies from over 60 countries currently order from Abcam. There are currently over 100,000 bio-scientists subscribed to the Abcam email list. As well as selling direct to over 60 countries, Abcam also sells through official distributorships in Japan, South Korea, Taiwan, US and China.
Production/Operations
The Company has a fully integrated stock management system that automates the sales process from the time of receipt of order to the dispatch of the product and invoice. The average order is worth approximately £310.
Distribution/Routes to Market
Market & Competition
The research biochemicals market in the US is estimated by Frost & Sullivan at $1.7 billion in revenues in 2005 and wass estimated to grow to over $2.2 billion by 2009, which would represent a CAGR of 6.4% between…
